Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Peripheral and coronary endothelial dysfunction in type 2 diabetic patients may be influenced
by therapeutics. Using Radial flow monitoring and myocardial perfusion magnetic resonance
imaging, we designed a controlled randomized double blind study to test the hypothesis that
endothelial dysfunction will be reversed following 3 months of Metformin administration vs
gliclazide. 30 patients will be included.